FiLaC Laser Fistula Surgery: How Does It Work and Who Is Actually a Good Candidate?

Medicine Made Simple Summary
FiLaC, or Fistula-tract Laser Closure, is a minimally invasive treatment for selected anal fistulas. It uses a thin laser fibre placed inside the fistula tunnel to deliver controlled laser energy, with the aim of shrinking and closing the tract. Unlike a traditional fistulotomy, FiLaC is designed to avoid deliberately cutting the anal sphincter muscles. This makes it particularly relevant for fistulas where protecting bowel control is important. However, laser treatment is not suitable for every patient. The fistula’s location, complexity, previous treatment, infection and sphincter involvement all influence whether FiLaC is appropriate.
What Is an Anal Fistula?
An anal fistula is an abnormal tunnel that develops between the inside of the anal canal and the skin around the anus.
It commonly begins with an anal abscess. An abscess is a collection of pus caused by an infection. It can cause severe pain, swelling, redness and sometimes fever.
When an abscess drains, the immediate pressure and pain may disappear. But sometimes the pathway created by the infection remains.
That pathway becomes an anal fistula.
Some people notice a small opening near the anus that repeatedly produces pus or fluid. Others experience episodes of swelling and pain followed by drainage.
An established fistula usually does not heal permanently on its own. Treatment is often needed to close or remove the abnormal tunnel.
The challenge is that fistulas can pass through the anal sphincter muscles. These muscles help control bowel movements. Therefore, the surgeon must treat the fistula without unnecessarily damaging the sphincter.
This is where sphincter-preserving procedures such as FiLaC can become relevant.
What Does FiLaC Mean?
FiLaC stands for Fistula-tract Laser Closure.
The name describes what the procedure is designed to do.
A thin laser fibre is inserted into the fistula tract. Controlled laser energy is then delivered along the tunnel.
The heat produced by the laser causes the tissue around the fibre to shrink and encourages the fistula tract to close.
The important difference from a traditional fistulotomy is that FiLaC does not deliberately open the entire fistula through the sphincter muscle.
The procedure is therefore considered a sphincter-preserving technique.
Research has described FiLaC as a minimally invasive approach intended to treat selected fistulas while preserving external sphincter function.
Why Is Protecting the Sphincter So Important?
The anal sphincter is a group of muscles that helps you control gas and stool.
If a fistula passes through a significant amount of sphincter muscle, cutting through that muscle during surgery can increase the risk of continence problems.
For a simple fistula involving very little sphincter muscle, a procedure called a fistulotomy may be appropriate. During fistulotomy, the surgeon opens the fistula tract so it can heal as a wound.
But this approach may not be suitable for a high or complex fistula.
In these situations, the surgeon may consider a sphincter-preserving technique.
FiLaC is one such option.
The aim is to treat the fistula without deliberately dividing the sphincter.
This does not mean that FiLaC is automatically better than fistulotomy. It means that the two procedures may be appropriate for different types of fistulas.
How Is FiLaC Laser Fistula Surgery Performed?
The procedure is usually performed under anaesthesia.
Before treatment, the surgeon needs to understand the pathway of the fistula.
This is important because the laser fibre needs to be placed inside the actual fistula tract.
During the procedure, the surgeon identifies the fistula opening and introduces a thin laser fibre through the tract.
The laser energy is then delivered as the fibre is withdrawn.
The energy acts on the fistula lining and surrounding tissue, causing contraction and helping the tunnel close.
The external opening may also be treated depending on the surgical approach.
The procedure itself is relatively short in many cases. A patient information resource from Frimley Health NHS Foundation Trust states that laser ablation usually takes less than an hour.
After the procedure, the patient is observed for a period before going home.
Many patients can return home on the same day.
What Happens to the Fistula After the Laser Is Used?
It is important to understand that FiLaC does not simply “burn away” the fistula instantly.
The laser energy causes controlled tissue changes within the tract.
The aim is to shrink and close the abnormal tunnel.
The body then continues the healing process.
This means that you may still experience some discharge or mild soreness after the procedure.
The fistula does not necessarily look completely different immediately after surgery.
Healing takes time.
A small amount of discharge or bleeding can occur during recovery, and the amount should generally be assessed in the context of the overall healing process.
Who May Be a Good Candidate for FiLaC?
FiLaC is generally considered for selected patients where a sphincter-preserving approach is desirable.
This can include:
- Patients with transsphincteric fistulas, particularly when a conventional fistulotomy could involve cutting a significant amount of sphincter muscle.
- Some patients with recurrent fistulas.
- Patients where preserving the sphincter is an important consideration.
Published studies have included substantial numbers of patients with transsphincteric and previously treated fistulas. One systematic review found that about two-thirds of the patients studied had transsphincteric fistulas and around 60% had undergone previous surgical treatment, most commonly seton placement.
A long-term study involving 175 patients treated with FiLaC included 152 patients with transsphincteric fistulas. Most had also undergone prior drainage using a seton or silicon loop.
However, these study populations do not mean that every patient with a transsphincteric fistula is automatically suitable.
The surgeon still needs to assess the individual fistula.
Can FiLaC Be Used for a Recurrent Fistula?
It can be considered in selected recurrent cases.
A recurrent fistula means that the condition has returned after previous treatment.
Repeated surgery can create scar tissue and may increase concern about further damage to the sphincter.
For such patients, a sphincter-preserving approach may be attractive.
However, recurrence can also indicate that the fistula has complex anatomy.
There may be additional branches.
The internal opening may be difficult to identify.
There may be an abscess or another area of infection.
These factors can influence whether FiLaC is appropriate.
A previous operation does not automatically make someone a good candidate for laser treatment.
The entire fistula needs to be reassessed.
Does a Patient Need a Seton Before FiLaC?
Not always, but a seton may be used before FiLaC in selected patients.
A seton is a thin surgical material placed through the fistula tract to maintain drainage.
It is particularly useful when there is infection or when the fistula is complex.
The purpose is to prevent pus and fluid from becoming trapped while allowing inflammation to settle.
This can be part of a staged treatment plan.
Interestingly, a long-term study of 175 patients found that 81.8% had a seton or draining loop placed before FiLaC. Patients who had prior drainage had a higher primary healing rate in that study than those who did not.
This does not prove that every patient needs a seton before laser treatment.
It shows that staged drainage is commonly incorporated into treatment for complex fistulas.
Your surgeon will decide based on the presence of infection, abscess, drainage and fistula anatomy.
Can FiLaC Be Used If There Is an Abscess?
An active abscess generally needs to be addressed before definitive fistula closure.
An abscess is a collection of pus.
Trying to close a fistula while an active collection of infection remains may not be appropriate.
The first priority may therefore be drainage.
A seton may then be placed if needed.
Once the infection is controlled, the fistula can be reassessed.
This is why fistula treatment is sometimes performed in stages rather than during one operation.
The exact sequence depends on the patient.
Is FiLaC Suitable for Every Anal Fistula?
No.
This is one of the most important points patients should understand.
FiLaC is not a universal replacement for other fistula procedures.
A fistula may be too complex.
It may have several branches.
The internal opening may be difficult to identify.
There may be an abscess.
The tract may be unsuitable for the laser fibre.
There may be underlying Crohn's disease.
Previous treatment may have significantly changed the anatomy.
In these situations, another approach may be more appropriate.
Treatment should be selected according to the anatomy rather than simply because laser technology is available.
What Does the Research Say About FiLaC Success?
This is where patients need realistic information.
FiLaC can work, but it does not guarantee permanent healing.
Earlier research was encouraging.
A 2020 systematic review involving 476 patients reported a pooled success rate of 63% and a pooled complication rate of 8%. About 66% of patients in the studies had transsphincteric fistulas, and 60% had undergone previous surgery.
Another systematic review involving 454 patients reported a weighted mean primary healing rate of 67.3%. The overall success rate increased to 69.7% when FiLaC was reused in selected patients.
Long-term follow-up is particularly important.
A 10-year experience involving 175 patients reported a primary healing rate of 66.8% at a median follow-up of five years. Recurrence occurred in 11.4% of patients in that study.
More recent evidence is more cautious.
A 2025 systematic review and meta-analysis involving 1,503 patients reported a pooled primary healing rate of 57.46%, recurrence in 18.48% and reoperation in 36.49%. New-onset incontinence was uncommon at 0.57%.
These numbers show why patients should not be promised a specific success rate.
The outcome depends on the patient, the fistula, the technique and the surgeon's experience.
Does FiLaC Protect Bowel Control?
One of the main reasons FiLaC is considered is its sphincter-preserving design.
Because the laser is delivered inside the fistula tract rather than deliberately cutting across the sphincter, the procedure aims to reduce the risk of sphincter injury.
Studies have generally reported low rates of new continence problems.
The 2025 meta-analysis found new-onset incontinence in 0.57% of patients, while earlier pooled evidence reported a weighted continence-affection rate of approximately 1%, mainly minor soiling.
However, “low risk” does not mean “zero risk.”
Every procedure has potential complications.
Your surgeon should discuss the risks based on your specific anatomy.
What Are the Advantages of FiLaC?
The main potential advantages include:
- Sphincter preservation, particularly for high or complex fistulas where cutting through the sphincter could create a greater continence risk.
- A minimally invasive approach.
- Potentially a smaller external wound compared with some traditional approaches.
- Relatively quick recovery in selected patients.
Frimley Health NHS Foundation Trust describes laser ablation as a procedure associated with relatively little pain, a small wound, faster recovery and a low risk of bowel-control problems.
However, these potential benefits should be balanced against the possibility of incomplete healing or recurrence.
What Are the Limitations of FiLaC?
The biggest limitation is that it does not work for every fistula.
The available evidence also shows variable healing rates.
Some patients require another procedure after FiLaC.
The 2025 meta-analysis found a substantial reoperation rate across the studies it reviewed.
Another important limitation is that much of the evidence has historically come from observational studies rather than large randomised trials.
The 2020 systematic review specifically noted the need for randomised trials comparing FiLaC with other fistula procedures.
More recent expert recommendations have attempted to standardise the way FiLaC is performed, but further high-quality comparative research is still needed.
This means FiLaC should be presented as an established treatment option for selected patients, but not as a guaranteed or universally superior procedure.
What Is Recovery Like After FiLaC?
Recovery is often relatively straightforward.
You may experience mild soreness for a few days.
A small amount of discharge or bleeding can occur while the treated tract heals.
Gentle walking is generally encouraged.
Your surgeon may advise avoiding heavy lifting and strenuous exercise for a short period.
Keeping the area clean is important.
Warm water can be used to gently clean the area after bowel movements, and the skin should be dried without vigorous rubbing.
Constipation should also be avoided because straining can make the area uncomfortable.
Frimley Health NHS Foundation Trust notes that many patients can return to work or school within a few days depending on how they feel.
Your individual recovery may be different.
When Should You Contact Your Doctor After FiLaC?
Some discomfort and drainage can be expected.
However, certain symptoms should not be ignored:
- Severe or increasing pain should be assessed.
- Heavy bleeding requires medical attention.
- Fever can indicate infection.
- Increasing swelling may indicate an abscess.
- Foul-smelling discharge can also require review.
- Difficulty passing urine or stool should be reported.
These symptoms do not necessarily mean the procedure has failed.
They simply mean that your surgeon should assess the situation.
What If FiLaC Does Not Work?
Failure of FiLaC does not mean that you have run out of treatment options.
Some patients may undergo repeat laser treatment.
Others may be better suited to a different procedure.
In the long-term study of 175 patients, 26 patients underwent repeat FiLaC after failure, and 12 healed after the repeat laser procedure. The authors reported a secondary success rate of 73.7% in the overall group that underwent reoperation.
Other options can include LIFT, advancement flap, VAAFT or another appropriate sphincter-preserving procedure.
The next step depends on why the first treatment failed and what the fistula looks like after treatment.
What Should You Ask Your Surgeon Before Choosing FiLaC?
Before deciding on laser treatment, ask:
- Where does the fistula start and where does it travel?
- How much sphincter muscle is involved?
- Is it a simple or complex fistula?
- Is an MRI needed?
- Is there an abscess or secondary branch?
- Should a seton be placed before FiLaC?
- What is the surgeon's experience with FiLaC?
- What are the expected healing and recurrence rates for patients with fistulas similar to yours?
- What would be the next treatment if the fistula does not heal?
These questions can help you understand whether FiLaC is being recommended because it genuinely suits your anatomy or simply because it is available.
The Key Takeaway
FiLaC is a minimally invasive, sphincter-preserving treatment for selected anal fistulas.
It works by placing a thin laser fibre inside the fistula tract and delivering controlled energy to encourage the abnormal tunnel to shrink and close.
Its main attraction is that it aims to treat the fistula without deliberately cutting the sphincter muscles.
This can be particularly relevant for high or complex fistulas where protecting bowel control is important.
But FiLaC is not suitable for everyone.
The fistula needs to be carefully assessed.
Some patients may need an abscess drained first.
Some may benefit from a seton before laser treatment.
Others may be better suited to LIFT, an advancement flap, VAAFT or another procedure.
Research shows that FiLaC can achieve healing in many patients, but recurrence and the need for further treatment remain possible. Recent evidence reports a pooled primary healing rate of around 57%, while earlier studies reported higher rates.
This variation is important.
The right treatment is not necessarily the newest treatment.
It is the treatment that best matches the anatomy of your fistula and protects your long-term bowel function.
Conclusion
If you have been diagnosed with an anal fistula, hearing the word “laser” may make FiLaC sound like a simple modern solution.
The reality is more nuanced.
FiLaC is an important sphincter-preserving option, particularly for selected complex or transsphincteric fistulas.
It works by delivering controlled laser energy inside the fistula tunnel, encouraging the tract to close without deliberately cutting through the sphincter.
This can be valuable because preserving bowel control is one of the most important goals of fistula treatment.
But FiLaC is not suitable for every patient.
Your surgeon needs to understand the fistula's pathway, internal opening, branches, infection status and relationship with the sphincter before recommending it.
A seton may sometimes be placed first to control drainage.
In other cases, another sphincter-preserving procedure may provide a better option.
Most importantly, laser treatment should not be viewed as a guaranteed cure.
The evidence shows meaningful healing rates, but recurrence and further procedures remain possible.
If you are considering FiLaC, ask your surgeon why it is appropriate for your fistula, what alternatives exist and what happens if the first procedure does not completely heal the tract.
The best treatment is not simply the one with the most advanced technology.
It is the one that gives you the best balance between treating the fistula, reducing recurrence and protecting your ability to control bowel movements.
References and Sources
PubMed – A Systematic Review and Meta-analysis of the Safety and Efficacy of Fistula Laser Closure
PubMed – Treatment of Anal Fistula With FiLaC: Results of a 10-Year Experience With 175 Patients

















